Literature DB >> 8767104

Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.

F Cervantes1, J Briones, M Bruguera, C Font, J M Grau, C Rozman, E Montserrat.   

Abstract

In order to determine the frequency and characteristics of patients with liver abnormalities as the presenting manifestation of Hodgkin's disease (HD), 421 consecutive HD patients were studied. Six patients in the series (1.4%) presented with liver abnormalities that led to of a liver biopsy and the subsequent diagnosis of HD. All had fever prior to HD diagnosis, four frank jaundice, and one hepatic failure. No patient had pruritus. Moderate hepatomegaly was present in four patients. Cholestasis was observed in all cases; in most patients a moderate increase in the transaminase activity was also seen. Two patients had a mild rise in the serum LDH, four had leukopenia, and one eosinophilia. At liver histologic study, Reed-Sternberg cells were demonstrated in four patients; in the remaining two, the presence of atypical histiocytes, lymphocytes, and eosinophils was highly suggestive of HD, the latter diagnosis being confirmed by subsequent study of bone marrow and/or retroperitoneal lymphadenopathies. In three of the six patients, HD was not demonstrated in sites other than the liver. Three patients older than 60 years died shortly after HD diagnosis. By contrast, three patients younger than 40 years showed a dramatic response to chemotherapy: two of them had a further relapse, and one is considered cured after 14 years of continuous remission. Liver disease constitutes an infrequent form of HD presentation which must be included in the differential diagnosis of any patient with fever of unknown origin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8767104     DOI: 10.1007/s002770050186

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  Febrile cholestatic disease as an initial presentation of nodular lymphocyte-predominant Hodgkin lymphoma.

Authors:  Anna Mrzljak; Slavko Gasparov; Ika Kardum-Skelin; Vesna Colic-Cvrlje; Slobodanka Ostojic-Kolonic
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

2.  Cholestatic jaundice: a unique presentation leading to the diagnosis of HLH with Hodgkin lymphoma, HIV and EBV.

Authors:  Hira Shaikh; Soorih Shaikh; Amir Kamran; Prerna Mewawalla
Journal:  BMJ Case Rep       Date:  2018-05-12

3.  Unusual cause of cholestatic jaundice in a patient with AIDS.

Authors:  Su Bin Kim; Makardhwaj Sarvadaman Shrivastava; Jesus M Anampa; Marianna Strakhan
Journal:  BMJ Case Rep       Date:  2013-08-23

Review 4.  Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.

Authors:  Delia Rota Scalabrini; Daniela Caravelli; Fabrizio Carnevale Schianca; Lorenzo D'Ambrosio; Francesco Tolomeo; Paola Boccone; Antonio Manca; Giovanni De Rosa; Annamaria Nuzzo; Massimo Aglietta; Giovanni Grignani
Journal:  BMC Res Notes       Date:  2014-08-14

5.  CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function.

Authors:  Keyur Thakar; Aileen Novero; Arundhati Das; Adriana Lisinschi; Bella Mehta; Tauseef Ahmed; Delong Liu
Journal:  Biomark Res       Date:  2014-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.